MaveriX Oncology, Inc. — Form D
MaveriX Oncology, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-09. The offering totals $20.0M, of which $1.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-10-09
- Form: D
- Accession: 0001675815-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $1.8M
- Remaining: $18.2M
- Investors: 1
- Date of first sale: 2019-09-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-350656
Issuer
- Name: MaveriX Oncology, Inc.
- CIK: 0001675815
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 435 MIDDLEFIELD ROAD, PALO ALTO, CA, 94301
- Phone: 650-862-3872
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Steven A Everett | Director | PALO ALTO, CA |
| Kim A Nearing | Director | Palo Alto, CA |
| Riccardo A Panicucci | Director | Palo Alto, CA |
| Norbert A Prenzel | Director | Palo Alto, CA |
| Steven A Everett | Executive Officer | PALO ALTO, CA |
| Rick A Panicucci | Director | Palo Alto, CA |
Other filings by this issuer (1)
More